QQQ   321.97 (+2.49%)
AAPL   126.41 (+4.25%)
MSFT   236.33 (+1.70%)
FB   262.30 (+1.82%)
GOOGL   2,060.43 (+1.91%)
TSLA   706.36 (+4.57%)
AMZN   3,124.26 (+1.01%)
NVDA   546.10 (-0.45%)
BABA   240.27 (+1.06%)
CGC   34.74 (+6.08%)
GE   13.20 (+5.26%)
MU   94.00 (+2.70%)
NIO   49.42 (+7.95%)
AMD   85.73 (+1.44%)
T   28.25 (+1.29%)
F   11.97 (+2.31%)
ACB   11.17 (+6.18%)
DIS   194.83 (+3.06%)
BA   223.48 (+5.41%)
NFLX   546.93 (+1.50%)
BAC   35.86 (+3.31%)
QQQ   321.97 (+2.49%)
AAPL   126.41 (+4.25%)
MSFT   236.33 (+1.70%)
FB   262.30 (+1.82%)
GOOGL   2,060.43 (+1.91%)
TSLA   706.36 (+4.57%)
AMZN   3,124.26 (+1.01%)
NVDA   546.10 (-0.45%)
BABA   240.27 (+1.06%)
CGC   34.74 (+6.08%)
GE   13.20 (+5.26%)
MU   94.00 (+2.70%)
NIO   49.42 (+7.95%)
AMD   85.73 (+1.44%)
T   28.25 (+1.29%)
F   11.97 (+2.31%)
ACB   11.17 (+6.18%)
DIS   194.83 (+3.06%)
BA   223.48 (+5.41%)
NFLX   546.93 (+1.50%)
BAC   35.86 (+3.31%)
QQQ   321.97 (+2.49%)
AAPL   126.41 (+4.25%)
MSFT   236.33 (+1.70%)
FB   262.30 (+1.82%)
GOOGL   2,060.43 (+1.91%)
TSLA   706.36 (+4.57%)
AMZN   3,124.26 (+1.01%)
NVDA   546.10 (-0.45%)
BABA   240.27 (+1.06%)
CGC   34.74 (+6.08%)
GE   13.20 (+5.26%)
MU   94.00 (+2.70%)
NIO   49.42 (+7.95%)
AMD   85.73 (+1.44%)
T   28.25 (+1.29%)
F   11.97 (+2.31%)
ACB   11.17 (+6.18%)
DIS   194.83 (+3.06%)
BA   223.48 (+5.41%)
NFLX   546.93 (+1.50%)
BAC   35.86 (+3.31%)
QQQ   321.97 (+2.49%)
AAPL   126.41 (+4.25%)
MSFT   236.33 (+1.70%)
FB   262.30 (+1.82%)
GOOGL   2,060.43 (+1.91%)
TSLA   706.36 (+4.57%)
AMZN   3,124.26 (+1.01%)
NVDA   546.10 (-0.45%)
BABA   240.27 (+1.06%)
CGC   34.74 (+6.08%)
GE   13.20 (+5.26%)
MU   94.00 (+2.70%)
NIO   49.42 (+7.95%)
AMD   85.73 (+1.44%)
T   28.25 (+1.29%)
F   11.97 (+2.31%)
ACB   11.17 (+6.18%)
DIS   194.83 (+3.06%)
BA   223.48 (+5.41%)
NFLX   546.93 (+1.50%)
BAC   35.86 (+3.31%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 InnovivaKiniksa PharmaceuticalsMacroGenicsAntibe TherapeuticsAntibe Therapeutics
SymbolNASDAQ:INVANASDAQ:KNSANASDAQ:MGNXNASDAQ:ATBPDOTCMKTS:ATBPD
Price Information
Current Price$11.54$22.03$24.95$3.98$3.98
52 Week RangeSellBuyBuyN/AN/A
MarketRank™
Overall Score1.41.71.40.10.1
Analysis Score0.53.52.30.00.0
Community Score2.12.42.50.00.0
Dividend Score0.00.00.00.00.0
Ownership Score3.32.51.70.00.0
Earnings & Valuation Score1.30.00.60.60.6
Analyst Ratings
Consensus RecommendationSellBuyBuyN/AN/A
Consensus Price Target$10.00$33.75$30.70N/AN/A
% Upside from Price Target-13.34% downside53.20% upside23.05% upsideN/AN/A
Trade Information
Market Cap$1.16 billion$1.40 billion$1.41 billion$1.54 billion$1.54 billion
Beta0.640.032.40.570.57
Average Volume544,134315,234784,06329,71029,710
Sales & Book Value
Annual Revenue$261.02 millionN/A$64.19 million$7.51 million$7.51 million
Price / Sales4.48N/A21.85205.09205.09
Cashflow$1.64 per shareN/AN/AN/AN/A
Price / Cash7.03N/AN/AN/AN/A
Book Value$3.38 per share$4.10 per share$4.71 per share$0.10 per share$0.10 per share
Price / Book3.41N/A5.3039.8039.80
Profitability
Net Income$157.29 million$-161,870,000.00$-151,810,000.00$-14,540,000.00$-14,540,000.00
EPS$1.43($2.99)($3.16)($0.50)($0.50)
Trailing P/E Ratio5.89N/AN/AN/AN/A
Forward P/E Ratio6.71N/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins67.16%N/A-204.31%-273.96%-273.96%
Return on Equity (ROE)53.99%-53.65%-65.84%-176.23%-150.49%
Return on Assets (ROA)28.92%-49.11%-49.41%-106.91%-98.51%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.72%N/AN/AN/AN/A
Current Ratio146.75%15.20%6.19%6.55%5.97%
Quick Ratio146.75%15.20%6.19%5.95%5.42%
Ownership Information
Institutional Ownership Percentage71.48%42.00%95.80%N/AN/A
Insider Ownership Percentage0.32%70.63%9.00%N/AN/A
Miscellaneous
Employees51353844747
Shares Outstanding101.39 million68.08 million56.20 million387.00 million387.00 million
Next Earnings Date5/5/2021 (Estimated)4/27/2021 (Estimated)5/4/2021 (Estimated)N/AN/A
OptionableOptionableNot OptionableOptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.